Dyspepsia - proton pump inhibitors (replaced by CG17)
The clinical and cost effectiveness of proton pump inhibitors for the treatment of dyspepsia
Summary
This guidance has been replaced by CG17 Dyspepsia: Managing dyspesia in adults in primary care .
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA7
Issued: July 2000
How this guidance was produced